Intercept Pharmaceuticals, Inc. (ICPT) Stock Analysis

DELISTED 2023

What happened to Intercept Pharmaceuticals, Inc. (ICPT) stock?

Intercept Pharmaceuticals, Inc. (ICPT) no longer trades on public markets. It was delisted in November 2023. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: November 2023
Last recorded price (historical):: $19.00 (last quote on record before the November 2023 delisting; historical, not a current quote)

MCap: $795M| P/E Ratio: 5.57| Vol: 3.91M| 52-wk range: $8.82 – $21.86

P/E 5.57 means the share price is 5.57 times one year of earnings per share. Market cap $795M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Intercept Pharmaceuticals, Inc. (ICPT). Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for progressive non-viral liver diseases. Its primary product, Ocaliva, is used to treat primary biliary cholangitis.

Last analyzed: May 6, 2026

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for progressive non-viral liver diseases. Its primary product, Ocaliva, is used to treat primary biliary cholangitis.

Intercept Pharmaceuticals, Inc. (ICPT) Healthcare & Pipeline Overview

Employees341

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 75% (not a measure of the evidence) Updated: May 6, 2026

More about this archive record

Can I still buy ICPT shares?

No. ICPT stopped trading on public markets in November 2023, so the shares are not available through a broker. Anything you see quoted for ICPT elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before ICPT stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Intercept Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated May 6, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: May 6, 2026.

Data provided for informational purposes only.